The Drug Information Association (DIA) has chosen Basel in Switzerland as the location for the 30th anniversary of its EuroMeeting in 2018. The event will take place from 17 to 19 April.
The congress will focus on increased collaboration between the regulatory and the health technology assessment (HTA) / payer environment, and to reflect this area of increasing importance, a new steering committee structure, according to DIA.
The central themes for the EuroMeeting will include:
The co-chairs for the 2018 EuroMeeting are Luca Pani, from the European Medicines Agency in London, and Michelle Rohrer, global head of product development regulatory & policy at Roche in Basel.
The deadline for submission of abstracts is 26 June 2017.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.